Delivery Order SPE2DB22D3501-SPE2DB25FWE60
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,386.42 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,123.36 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX) valued at $999.99 billion and...
- The Defense Logistics Agency awarded a $19,352.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ACTEMRA 400 mg/20 mL vials. The contract, executed on August 6, 2025, with ultimate completion by August 7, 2025, represents a competitively awarded non-set-aside procurement with performance to be completed in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $3,729.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Actemra 200 mg/10 mL vials. The contract, which is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $5,761.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of ACTEMRA 162 mg/0.9 mL syringes. The award, with an ultimate completion date of September 9, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,600.42 to AmerisourceBergen Drug Corp for the supply of ACTEMRA 162 mg/0.9 mL syringes on July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of July 29, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a $13,171.30 delivery order to AmerisourceBergen Drug Corp for 4,568,832,740 units of Actemra 400 mg/20 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued...
- The Defense Logistics Agency (DLA) awarded a $15,029.42 delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 ml vials on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside, firm fixed price contract represents a single delivery order for a pharmaceutical product to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a delivery order on June 2, 2025, by the Defense Logistics Agency to supply ACTEMRA 162 mg/0.9 mL syringes valued at $3,760.51 with a completion date of June 3, 2025. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials with a ceiling value of $6,630.33. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of June 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...